A bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settings

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Sarkar, Susmita ^a   Tang, Xinli L ^a   Das, Dipankar ^a,d   Spencer, John S ^b   Lowary, Todd L ^c   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d Indian Immunologicals Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HORSERADISH PEROXIDASE; LIPOARABINOMANNAN; LIPOARABINOMANNAN ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BIOTIN; BISPECIFIC ANTIBODY; BOVINE SERUM ALBUMIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; BLOOD ANALYSIS; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOSWAB ASSAY; LIMIT OF DETECTION; MULTICENTER STUDY; NONHUMAN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS; ANIMAL; CATTLE; CELL LINE; DIAGNOSTIC PROCEDURE; HEALTH CARE PLANNING; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; RAT; STAINING; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BIOTIN; BLOTTING, WESTERN; CATTLE; CELL LINE; CLINICAL LABORATORY TECHNIQUES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEALTH RESOURCES; HUMANS; LIMIT OF DETECTION; LIPOPOLYSACCHARIDES; MYCOBACTERIUM TUBERCULOSIS; RABBITS; RATS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN, BOVINE; STAINING AND LABELING; TUBERCULOSIS;

EID: 84857402379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032340     Document Type: Article

References (57)

1. World Health Organisation website. Available: http://www.who.int/tb/publications/global_report/2009/pdf/report_without_annexes.pdf. Accessed 2011 Feb 3.
2. Inderlied CB, Kemper A, Bermúdez LE, (1993) The Mycobacterium avium complex. Clin Microbiol Rev 6: 266-310.
3. Stop TB website. Available: http://www.stoptb.org/assets/documents/global/plan/SP%20Stop%20TB%20Dia%20WG%20-FINAL-Dec2005.pdf. Accessed 2011 Feb 3.
4. Madariaga MG, Jalali Z, Swindells S, (2007) Clinical utility of interferon gamma assay in the diagnosis of tuberculosis. J Am Board Fam Med 20: 540-547.
5. Lalvani A, Millington KA, (2008) Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev 8: 147-152.
6. Campos M, Quartin A, Mendes E, Abreu A, Guerevich S, et al. (2008) Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test. Am J Resp Crit Care Med 178: 300-305.
7. Theron G, Pooran A, Peter J, van Zyl-Smit R, Mishra HK, et al. (2011) Do adjunct TB tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Eur Respir J. Nov 10. [Epub ahead of print].
8. Pai M, Kalantri S, Dheda K, (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
9. Dorman SE, (2010) New diagnostic tests for tuberculosis: bench, bedside, and beyond. Clin Infect Dis 50: S173-177.
10. Luetkemeyer AF, (2010) Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States. Top HIV Med 18: 143-148.
11. Chaudhary M, Gupta S, Khare S, Lal S, (2010) Diagnosis of tuberculosis in an era of HIV pandemic: a review of current status and future prospects. Indian J Med Microbiol 28: 281-289.
12. Gennaro ML, (2000) Immunologic diagnosis of tuberculosis. Clin Infect Dis 30: S243-246.
13. Sarkar S, Suresh MR, (2011) An overview of tuberculosis chemotherapy- a literature review. J Pharm Pharm Sci 14: 148-161.
14. Abebe F, Holm-Hansen C, Wiker HG, Bjune G, (2007) Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol 66: 176-191.
15. Strohmeier GR, Fenton MJ, (1999) Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes and Infect 1: 709-717.
16. Chatterjee D, Khoo KH, (1998) Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8: 113-120.
17. Russell D, (1998) Release and trafficking of lipid components from mycobacterial phagosomes in infected macrophages. Presented at the Keystone conference, TB: Molecular Mechanisms and Immunologic Aspects, Keystone, Colorado.
18. Briken V, Porcelli SA, Besra GS, Kremer L, (2004) Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Molec Microbiol 53: 391-403.
19. Sada E, Aguilar D, Torres M, Herrera T, (1992) Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Microbiol 30: 2415-2418.
20. Arias-Bouda LMP, Nguyen L, Ho L, Kuijper S, Jansen H, et al. (2000) Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Microbiol 38: 2278-2283.
21. Boehme C, Molokova E, Minja F, Geis S, Loscher T, et al. (2005) Detection of mycobacterial LAM with an antigen capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 99: 893-900.
22. Patel VB, Singh R, Connolly C, Kasprowicz V, Zumla A, et al. (2010) Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalencesetting. PLoS One 5: e15664.
23. Dheda K, Van-Zyl Smit RN, Sechi LA, Badri M, Meldau R, et al. (2009) Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 4: e4689.
24. Patel VB, Bhigjee AI, Paruk HF, Singh R, Meldau R, et al. (2009) Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource -poor high-HIV prevalence setting. Cerebrospinal Fluid Res 6: 13.
25. Mahadevan S, (1997) Clinical utility of serodiagnosis of tuberculosis. Indian J Pediatr 64: 97-103.
26. Bhatnagar P K, Das D, Suresh MR, (2008) Sequential affinity purification of peroxidase tagged bispecific anti-SARS CoV antibodies on phenylboronic acid agarose. J Chromatogr B Analyt Technol Biomed Life Sci 863: 235-241.
27. Gadikota RR, Callam CS, Appelmelk BJ, Lowary TL, (2003) Synthesis of oligosaccharide fragments of mannosylated lipoarabinomannan appropriately functionalized for neoglycoconjugate preparation. J Carbohydr Chem 22: 459-480.
28. Murase T, Zheng RB, Joe M, Bai Y, Marcus SL, et al. (2009) Structural insights into antibody recognition of mycobacterial polysaccharides. J Mol Biol 392: 381-392.
29. Kaur D, Lowary TL, Vissa VD, Crick DC, Brennan PJ, (2002) Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology 148: 3049-3057.
30. Hunter SW, Gaylord H, Brrennan PJ, (1986) Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tuberle bacilli. J Biol Chem 261: 12345-12351.
31. Rademacher C, Shoemaker GK, Kim H, Zheng RB, Taha H, et al. (2007) Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition. J Am Chem Soc 129: 10489-10502.
32. Tong M, Jacobi CE, van de Rijke FM, Kuijper S, van de Werken S, et al. (2005) A multiplexed and miniaturized serological tuberculosis assay identifies antigens that discriminate maximally between TB and non-Tb sera. J Immunol Methods 301: 154-163.
33. The Tuberculosis Trial Consortium (2002) Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 360: 528-34.
34. Spencer JS, Kim HJ, Wheat WH, Chatterjee D, Balagon MV, et al. (2011) Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol 18 (2): 260-267.
35. Shahhosseini S, Das D, Qiu X, Feldmann H, Jones SM, et al. (2007) Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens. J Virol Methods 143: 29-37.
36. Shahhosseini S, Guttikonda S, Bhatnagar P, Suresh MR, (2006) Production and characterization of monoclonal antibodies against shope fibroma virus superoxide dismutase and glutathione-s-transferase. J Pharm Pharmaceut Sci 9: 165-168.
37. Das D, Suresh MR, (2005) Producing bispecific and bifunctional antibodies. Methods Mol Med 109: 329-346.
38. Tang XL, Peppler MS, Irvin RT, Suresh MR, (2004) Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertusis. Clin Diag Lab Immunol 11: 752-757.
39. Kreutz FT, Xu D, Suresh MR, (1998) A new method to generate quadromas by electrofusion and FACS sorting. Hybridoma 17: 267-273.
40. Suresh MR, Cuello AC, Milstein C, (1986) Bispecific monoclonal antibodies from hybrid hybridomas. Methods Enzymol 121: 210-228.
41. Guttikonda S, Tang XL, Yang BM, Armstrong GD, Suresh MR., Monospecific and bispecific antibodies against E. coli O157 for diagnostics. J Immunol Methods 2007; 327: 1-9.
42. Miles SA, Balden E, Magpantay L, Wei L, Leiblein A, et al. (1993) Rapid serologic testing with immune-complex dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med 328: 297-302.
43. Krijger FW, van Lieshout L, Deelder AM, (1994) A simple technique to pretreat urine and serum samples for quantitation of schistosome circulating anodic and cathodic antigen. Acta Trop 56: 55-63.
44. Koraka P, Burghoorn-Maas CP, Falconar A, Setiati TE, Djamiatun K, et al. (2003) Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol 41: 4154-4159.
45. Józefowski S, Sobota A, Kwiatkowska K, (2008) How Mycobacterium tuberculosis subverts host immune responses. BioEssays 30: 943-954.
46. Lipman NS, Jackson LR, Trudel LJ, W-Garcia F, (2005) Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications and information resources. Inst Lab Anim Res J 46: 258-268.
47. Suresh MR, Cuello AC, Milstein C, (1986) Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays. Proc Natl Acad Sci U S A 83: 7989-7993.
48. Ritter MA, (2000) Polyclonal and monoclonal antibodies. Methods Mol Med 40: 23-34.
49. Cao Y, Suresh MR, (1998) Bispecific antibodies as novel bioconjugates. Bioconjug Chem 9: 635-44.
50. Reither K, Saathoff E, Jung J, Minja LT, Kroidl I, et al. (2009) Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis 9: 141.
51. Dheda K, Davids V, Lenders L, Roberts T, Meldau R, et al. (2010) Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 5: e9848.
52. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, et al. (2010) Urine for the diagnosis of tuberculosis: current approaches, clinical applicability,and new developments. Curr Opin Pulm Med 16: 262-270.
53. Lawn SD, Kerkhoff AD, Vogt M, Wood R, (2011) Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis Oct 17. [Epub ahead of print].
54. Bennion BJ, Daggett V, (2003) The molecular basis for the chemical denaturation of proteins by urea. Proc Natl Acad Sci U S A 100: 5142-5147.
55. Vasudevachari MB, Salzman NP, Woll DR, Mast C, Uffelman KW, et al. (1993) Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay. J Clin Immunol 13: 185-192.
56. Keeler E, Perkins MD, Small P, Hanson C, Reed S, et al. (2006) Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444: 49-57.
57. Mabey D, Peeling RW, Ustianowski A, Perkins MD, (2004) Diagnostics for the developing world. Nat Rev Microbiol 2: 231-240.